Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
This rebrand happened after increased scrutiny of GLP-1 naming conventions
Reported eligibility frameworks have referenced combinations such as: Overweight or obesity alongside prediabetes or cardiovascular disease Obesity combined with conditions like heart failure, hypertension, or chronic kidney disease Ultimately, however, final eligibility rules, prior authorization requirements, and clinical thresholds will be determined by participating Medicare Part D plans and CMS guidance closer to launch
Kalow W, Tang BK
See full profile.
"starting at" prices mislead because dose-step structures raise the bill once you reach maintenance
US$ 21.03
US$ 26.60
US$ 28.19
US$ 24.57
US$ 29.85
US$ 29.67
